Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.027 | 0.7 |
mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.017 | 0.7 |